Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

Ruxolitinib cream may help treat severe hair loss in children.

Microinfusion of methotrexate can help treat frontal fibrosing alopecia.

Cyclophosphamide can cause serious short-term and long-term side effects, including increased cancer risk and infertility.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Folate may reduce methotrexate side effects in psoriasis patients, but its impact on effectiveness is unclear.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

The NUDT15 gene variant causes severe side effects from azathioprine in some Indian patients.

Some drugs used to treat immune conditions may cause different types of hair loss.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

A hair growth ointment improved hair length in a family with a genetic hair growth condition.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Cyclosporine is more effective than betamethasone for treating alopecia areata, despite mild side effects.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Some blood donors on teratogenic drugs may have unsafe drug levels, suggesting a need for better deferral policies.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Adjusting minoxidil dosage may be safer than using bicalutamide for hair loss in women.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.

Cyclosporine can cause a unique skin condition called "cyclosporine-induced folliculodystrophy."